MB
Mereo BioPharma Group PLC ADR
🇺🇸XNAS.MREOUnited StatesHealthcare
$0.27USDdown -0.02 (-6.9%)OpenDelayed5:16 PM
Price$0.27-0.02 (-6.9%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US5894921072
- CUSIP
- 589492107
Company
- Employees
- 39
- Headquarters
- London, United States
- CEO
- Dr. Denise Vera Scots-Knight Ph.D.
Market
- Shares outstanding
- 159.7M
- Market cap
- $43.12M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $46.31M
- EPS LTM
- -$0.18calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.54calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$28.08M+43.26%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$25.35M+23.74%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.